Cargando…

A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery

PURPOSE: To review brachytherapy use in recurrent head and neck carcinoma (RHNC) with focus on its efficacy and complication rates. MATERIAL AND METHODS: A literature search of PubMed, Ovid, Google Scholar, and Scopus was conducted from 1990 to 2017. Publications describing treatment of RHNC with br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodin, Julianna, Bar-Ad, Voichita, Cognetti, David, Curry, Joseph, Johnson, Jennifer, Zender, Chad, Doyle, Laura, Kutler, David, Leiby, Benjamin, Keane, William, Luginbuhl, Adam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251444/ https://www.ncbi.nlm.nih.gov/pubmed/30479623 http://dx.doi.org/10.5114/jcb.2018.79399

Ejemplares similares

Carotid dosimetry after re-irradiation with (131)Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
por: Walsh, Amanda, et al.
Publicado: (2019)

Multi-Institutional Study Validates Safety of Intraoperative Cesium-131 Brachytherapy for Treatment of Recurrent Head and Neck Cancer
por: Luginbuhl, Adam, et al.
Publicado: (2021)

Single institution implementation of permanent (131)Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinoma
por: Bar-Ad, Voichita, et al.
Publicado: (2019)

Cesium-131 Interstitial Brachytherapy for Recurrent Malignancies of Skull Base
por: Savard, Corey, et al.
Publicado: (2019)

A nomogram to determine required seed air kerma strength in planar (131)Cesium permanent seed implant brachytherapy
por: Hubley, Emily, et al.
Publicado: (2019)

Impact of adjuvant radiation therapy after definitive surgery in senior adults >80 years old with advanced head and neck squamous cell carcinoma on overall survival
por: Butkus, Joann M., et al.
Publicado: (2022)

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
por: Johnson, Jennifer M, et al.
Publicado: (2023)

Head and neck surgery global outreach: Ethics, planning, and impact
por: Luginbuhl, Adam, et al.
Publicado: (2021)

Neither high-dose nor low-dose brachytherapy increases flap morbidity in salvage treatment of recurrent head and neck cancer
por: Henderson, Peter W., et al.
Publicado: (2016)

Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes
por: Pham, Anthony, et al.
Publicado: (2015)

Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
por: Bovenzi, Cory D., et al.
Publicado: (2015)

Permanent Interstitial Cesium-131 Brachytherapy in Treating High-Risk Recurrent Head and Neck Cancer: A Prospective Pilot Study
por: Kharouta, Michael, et al.
Publicado: (2021)

Metformin effects on head and neck squamous carcinoma microenvironment: Window of opportunity trial
por: Curry, Joseph, et al.
Publicado: (2017)

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
por: Curry, Joseph M., et al.
Publicado: (2013)

Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Manukian, Gregor, et al.
Publicado: (2019)

Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect
por: Merlino, Dante J., et al.
Publicado: (2020)

Percutaneous gastrostomy site metastasis from head and neck tumors: A single institution case series
por: Metkus, James S., et al.
Publicado: (2017)

Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Kumar, Ayan Tyagi, et al.
Publicado: (2019)

Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy
por: RUDZIANSKAS, V., et al.
Publicado: (2012)

Reintroduction
por: Bindenagel Šehović, Annamarie
Publicado: (2017)

The role of salvage surgery with interstitial brachytherapy for the Management of Regionally Recurrent Head and Neck Cancers
por: Khan, Nayel, et al.
Publicado: (2019)

Brachytherapy in head and neck malignancies: Indian Brachytherapy Society (IBS) recommendations and guidelines
por: Bhalavat, Rajendra, et al.
Publicado: (2020)

Cancer-Associated Fibroblast Density, Prognostic Characteristics, and Recurrence in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Knops, Alexander M., et al.
Publicado: (2020)

Sentinel Node Biopsy in Young Patients with Atypical Melanocytic Tumors of the Head and Neck
por: Pfau, David, et al.
Publicado: (2019)

Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy
por: Pellizzon, Antonio Cassio Assis, et al.
Publicado: (2006)

High-dose-rate interstitial brachytherapy in recurrent head and neck cancer: an effective salvage option
por: Bhalavat, Rajendra, et al.
Publicado: (2018)

Patient-Reported Pain and Opioid Use After Ambulatory Head and Neck Surgery
por: Cheng, Michael Z., et al.
Publicado: (2021)

Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy
por: Kovács, György
Publicado: (2014)

Preoperative cephalometric analysis to predict transoral robotic surgery exposure
por: Luginbuhl, Adam, et al.
Publicado: (2014)

Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma
por: Luginbuhl, Adam J., et al.
Publicado: (2022)

Efficacy and Safety of Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Wu, Chunrong, et al.
Publicado: (2020)

Metformin Clinical Trial in HPV+ and HPV– Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate
por: Curry, Joseph M., et al.
Publicado: (2018)

Subspecies hybridization as a potential conservation tool in species reintroductions
por: Zecherle, Lilith J., et al.
Publicado: (2021)

Permanent Interstitial Brachytherapy for Previously Irradiated Head and Neck Cancer
por: Breen, William, et al.
Publicado: (2018)

Reintroduction of Imatinib in GIST
por: Reid, T.
Publicado: (2013)

Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19
por: Yao, Peter, et al.
Publicado: (2021)

Recurrence and Severe Worsening of Hepatotoxicity After Reintroduction of Atorvastatin in Combination With Ezetimibe
por: Bergland Ellingsen, Silje, et al.
Publicado: (2017)

Is there any place for LDR brachytherapy for head and neck carcinomas in HDR era?
por: Fijuth, Jacek
Publicado: (2009)

Outcomes of Venous End‐to‐Side Microvascular Anastomoses of the Head and Neck
por: Stewart, Matthew, et al.
Publicado: (2020)

Single-fraction image-guided high-dose-rate brachytherapy for head and neck cancer: three cases of palliative brachytherapy
por: Ota, Yoshiaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kuvdu5otftjpkg1bgcp69hh64e